A panel of experts believes genetic testing of individuals at risk of familial hypercholesterolemia (FH) could “alter the natural history” of the condition, which is estimated to be undiagnosed in more than 27 million people worldwide, including more than 1 million in the United States.

Higher body mass index (BMI) as a young adult may result in higher blood pressure (BP) and left ventricle mass index, resulting in changes to the heart structure, researchers report in the American Heart Association’s (AHA) journal Circulation.

The FDA approved the FreeStyle Libre flash glucose monitoring system, which works for up to 14 days at a time, according to an announcement from device maker Abbott.

CMS’s advisory committee appears to be split on whether procedural volume requirements should be required for centers to begin and maintain transcatheter aortic valve replacement (TAVR) programs.

Postmenopausal women with high levels of high-density lipoproteins (HDL) did not have the same cardioprotective benefits typically seen in women of other ages, researchers reported in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology.

Intensive blood pressure lowering helped reduce the risk of mild cognitive impairment (MCI), according to a substudy from the SPRINT trial presented last week at the Alzheimer’s Association International Conference in Chicago.

Patients who undergo coronary artery bypass grafting (CABG) have shorter operations, fewer complications and better survival rates if they have surgeons who are subspecialized in CABG, researchers report in The Annals of Thoracic Surgery.

Siemens Healthineers received FDA approval of its High-Sensitivity Troponin I assays (TnIH)1 for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The new troponin assays will allow physicians to correctly diagnose patients for acute myocardial infarction (MI).